TLR2 and Sepsis: Regardless of the clinical outcome, 19 patients with severe sepsis were treated with GM-CSF, their HLA-DR expression in circulating mononuclear cells increased, and the release of pro-inflammatory cytokines was substantially improved when TLR2 or TLR4 ligand was administered126.